ProfileGDS4718 / 219110_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 87% 90% 90% 89% 96% 95% 91% 90% 90% 90% 87% 96% 95% 96% 93% 92% 92% 94% 88% 89% 91% 91% 91% 91% 95% 90% 94% 90% 95% 94% 96% 87% 89% 90% 93% 96% 91% 90% 90% 91% 95% 92% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.5880192
GSM549102patient 115, normal, homogenized [OPG study]8.751787
GSM549104patient 119, normal, homogenized [OPG study]9.1589590
GSM549108patient 138, normal, homogenized [OPG study]9.1794190
GSM549119patient 077, normal, homogenized [OPG study]8.9859489
GSM549133patient 032, cancer, homogenized [OPG study]10.545696
GSM549139patient 042, cancer, homogenized [OPG study]10.27795
GSM549099patient 107, normal, homogenized [OPG study]9.3514991
GSM549109patient 139, normal, homogenized [OPG study]9.2060690
GSM549110patient 046, normal, homogenized [OPG study]9.2877490
GSM549114patient 063, normal, homogenized [OPG study]9.4305890
GSM549122patient 082, normal, homogenized [OPG study]8.6760587
GSM549134patient 033, cancer, homogenized [OPG study]10.390696
GSM549136patient 036, cancer, homogenized [OPG study]10.282695
GSM549140patient 044, cancer, homogenized [OPG study]10.551196
GSM549111patient 047, normal, homogenized [OPG study]9.7909293
GSM549113patient 057, normal, homogenized [OPG study]9.669492
GSM549132patient 031, cancer, homogenized [OPG study]9.5778792
GSM549137patient 038, cancer, homogenized [OPG study]9.8702494
GSM549142patient 047, cancer, homogenized [OPG study]8.4321788
GSM549100patient 110, normal, homogenized [OPG study]9.0687189
GSM549107patient 135, normal, homogenized [OPG study]9.375491
GSM549115patient 068, normal, homogenized [OPG study]9.5228991
GSM549116patient 072, normal, homogenized [OPG study]9.3821191
GSM549120patient 078, normal, homogenized [OPG study]9.4252491
GSM549131patient 030, cancer, homogenized [OPG study]10.341295
GSM549118patient 074, normal, homogenized [OPG study]9.3354990
GSM549129patient 027, cancer, homogenized [OPG study]9.8697894
GSM549123patient 088, normal, homogenized [OPG study]9.3122490
GSM549124patient 006, cancer, homogenized [OPG study]10.072795
GSM549126patient 015, cancer, homogenized [OPG study]9.9725794
GSM549128patient 025, cancer, homogenized [OPG study]10.396596
GSM549103patient 117, normal, homogenized [OPG study]8.5413187
GSM549117patient 073, normal, homogenized [OPG study]9.1303289
GSM549138patient 041, cancer, homogenized [OPG study]9.2187890
GSM549141patient 045, cancer, homogenized [OPG study]9.7624693
GSM549130patient 028, cancer, homogenized [OPG study]10.351896
GSM549101patient 111, normal, homogenized [OPG study]9.3878391
GSM549105patient 128, normal, homogenized [OPG study]9.1694790
GSM549106patient 134, normal, homogenized [OPG study]9.3374890
GSM549112patient 048, normal, homogenized [OPG study]9.4115691
GSM549125patient 011, cancer, homogenized [OPG study]10.023395
GSM549127patient 024, cancer, homogenized [OPG study]9.4799192
GSM549135patient 035, cancer, homogenized [OPG study]9.9616194